<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Brucellosis: Epidemiology, microbiology, clinical manifestations, and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Brucellosis: Epidemiology, microbiology, clinical manifestations, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Brucellosis: Epidemiology, microbiology, clinical manifestations, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mile Bosilkovski, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Brucellosis (also known as 'undulant fever,' 'Mediterranean fever,' or 'Malta fever') is a zoonotic infection transmitted to humans from infected animals (cattle, sheep, goats, camels, pigs, or other animals) by ingestion of food products (such as unpasteurized dairy products) or by contact with tissue or fluids. It is the most common zoonosis worldwide and is an important public health problem in many resource-limited settings [<a href="#rid1">1-3</a>]. </p><p>The epidemiology, microbiology, clinical manifestations, and diagnosis of brucellosis will be reviewed here. The treatment and prevention of brucellosis are discussed separately. (See  <a class="medical medical_review" href="/d/html/121314.html" rel="external">"Brucellosis: Treatment and prevention"</a>.)</p><p class="headingAnchor" id="H971483824"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H2161800666"><span class="h2">Geographic distribution</span><span class="headingEndMark"> — </span>Endemic areas for brucellosis include countries of the Mediterranean basin, Middle East, Central Asia, China, the Indian subcontinent, sub-Saharan Africa, and parts of Mexico and Central and South America  (<a class="graphic graphic_table graphicRef121902" href="/d/graphic/121902.html" rel="external">table 1</a>) [<a href="#rid4">4,5</a>]. </p><p>Worldwide, approximately 500,000 cases are reported annually [<a href="#rid6">6</a>], and there are an estimated 2.4 billion people at risk [<a href="#rid7">7</a>]. All age groups are affected. The prevalence of brucellosis has been increasing due to growing international tourism, trade, and migration [<a href="#rid8">8,9</a>].</p><p>In the United States, 100 to 200 cases of human brucellosis are reported annually; most of them are due to <em>Brucella melitensis</em> [<a href="#rid4">4</a>]. However, true incidence has been estimated at 5 to 12 times greater, mainly attributable to foodborne illness [<a href="#rid10">10</a>]. Imported unpasteurized dairy products, such as fresh goat or sheep cheese from neighboring countries (particularly Mexico), are an important source of infection [<a href="#rid4">4,9,11</a>]. In addition, transmission of brucellosis in association with consumption of unpasteurized milk from domestic sources has been described [<a href="#rid12">12-14</a>]. </p><p>Brucellosis has been reported among wildlife in some regions [<a href="#rid15">15</a>]. In Australia and the United States, <em>Brucella suis</em> has been observed in approximately 20 percent of feral swine, and infection among hunters has been described [<a href="#rid16">16-18</a>]. Approximately 25 to 30 of cases reported annually to the United States Centers for Disease Control are due to <em>B. suis</em>; nationwide, 18 to 53 percent of feral swine are carriers of <em>B. suis </em>[<a href="#rid19">19</a>] and almost all cases are diagnosed in feral swine hunters [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H563071913"><span class="h2">Transmission</span><span class="headingEndMark"> — </span>The most common mechanisms for transmission of brucellosis to humans are [<a href="#rid1">1,2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Consumption of infected, unpasteurized animal products</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Contact of skin or mucous membranes with infected animal tissue (such as placenta or miscarriage products) or infected animal fluids (such as blood, urine, or milk) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inhalation of infected aerosolized particles</p><p></p><p>Consumption of unpasteurized dairy products (especially raw milk, soft cheese, butter, and ice cream) is the most common means of transmission [<a href="#rid1">1,20-22</a>]. Hard cheese, yogurt, and sour milk are less hazardous, since fermentation takes place. Infection due to <em>Brucella</em> RB51 (a live attenuated cattle vaccine strain that can be shed in milk) has been acquired via consumption of unpasteurized milk [<a href="#rid23">23</a>]. Consumption of raw or undercooked muscle tissue or organ meat (such as liver and spleen) are less common modes of transmission [<a href="#rid1">1</a>].</p><p>Brucellosis is an occupational disease in shepherds, abattoir workers, veterinarians, dairy-industry professionals, and laboratory personnel (including laboratory workers handling <em>Brucella</em> cultures and workers preparing brucellosis vaccines for animal use)  (<a class="graphic graphic_table graphicRef78971" href="/d/graphic/78971.html" rel="external">table 2</a>).</p><p>Rare cases of human-to-human transmission via blood transfusion, tissue transplantation, breastfeeding, sexual contact, congenital transmission, and nosocomial infection have been described [<a href="#rid24">24-27</a>]. Congenital brucellosis is rare; transmission may occur transplacentally during maternal bacteremia. Neonatal brucellosis may be acquired via contact with body fluids during delivery or via breastfeeding in the postpartum period [<a href="#rid3">3,25,28</a>]. Nosocomial transmission has occurred among health care workers who did not adhere to precautions and acquired the infection during obstetrical delivery or while caring for patients [<a href="#rid24">24,25</a>].  </p><p class="headingAnchor" id="H2603440943"><span class="h1">MICROBIOLOGY</span></p><p class="headingAnchor" id="H1677374642"><span class="h2">Taxonomy</span><span class="headingEndMark"> — </span>Several species are recognized within the <em>Brucella</em> genus [<a href="#rid29">29,30</a>].</p><p>Four <em>Brucella</em> species can cause human disease: <em>B. melitensis</em> (isolated from small ruminants such as sheep and goats, as well as camels), <em>B. abortus</em> (isolated from cattle), <em>B. suis</em> (isolated from swine), and <em>B. canis</em> (isolated from dogs). Worldwide, most human cases are caused by <em>B. melitensis </em>[<a href="#rid1">1</a>]. In general, human infection due to <em>B. melitensis</em> and <em>B. suis</em> is more virulent than human infection due to <em>B. abortus</em> or <em>B. canis </em>[<a href="#rid2">2,31-33</a>]. However, one study noted similar severity between infection due to <em>B. melitensis</em> and <em>B. abortus</em> [<a href="#rid34">34</a>].</p><p>Additional <em>Brucella</em> species have been isolated from animals or humans and detected as sporadic human pathogens; these include <em>B. pinipedialis</em> and <em>B. ceti</em> (isolated from marine mammals), <em>B. microti</em> (isolated from wildlife animals), <em>B. papionis</em> (isolated from baboons), <em>B. inopinata</em> (isolated from a human breast implant wound), <em>B. vulpis</em> (isolated from red foxes), <em>B. ovis</em> (isolated from sheep),<em> B. neotomae </em>(isolated from desert wood rats), and <em>B. pseudogrignonensis</em> (isolated from humans) [<a href="#rid35">35-43</a>]. </p><p class="headingAnchor" id="H1881899535"><span class="h2">Laboratory identification</span><span class="headingEndMark"> — </span>Laboratory workers should be informed about the diagnostic possibility of brucellosis in order to implement appropriate precautions and special culture techniques  (<a class="graphic graphic_table graphicRef78971" href="/d/graphic/78971.html" rel="external">table 2</a>).</p><p><em>Brucellae</em> are small, nonmotile, facultative intracellular aerobic rods, 0.5 to 0.7 micron in diameter and 0.6 to 1.5 micron in length [<a href="#rid44">44,45</a>]. Gram staining demonstrates single, tiny, gram-negative coccobacilli [<a href="#rid46">46</a>]. </p><p>Most strains require complex media for growth, which may be improved by adding serum or blood [<a href="#rid46">46</a>]. The optimum growth temperature is 35 to 37°C. Some biovars of <em>B. abortus</em> and <em>B. suis </em>require supplementary carbon dioxide [<a href="#rid47">47</a>]. Colonies are usually raised, convex, and 0.5 to 1.0 mm in diameter with a smooth, shiny surface [<a href="#rid46">46</a>].</p><p>The biphasic (solid and liquid) blood culture technique of Ruiz-Castaneda is still used in some resource-limited settings, but automated blood culture systems are more effective [<a href="#rid1">1</a>]. The biphasic technique requires 6 weeks of incubation; the yield is variable (40 to 90 percent in acute disease versus 5 to 20 percent in chronic, focal, and complicated disease) [<a href="#rid48">48</a>]. Most blood cultures are positive between 7 and 21 days [<a href="#rid49">49</a>]; subcultures should be performed for at least 4 weeks [<a href="#rid1">1</a>]. </p><p>The semiautomatic blood culture systems (Bactec and BacTAlert) shorten the detection time considerably; the presence of <em>Brucella</em> can be detected by the third day of incubation [<a href="#rid2">2,11,50,51</a>]. With automated blood culture systems, most isolates are recovered in one week; there is no need to incubate bottles longer than two weeks [<a href="#rid48">48,52</a>]. Cultures of other fluids or tissues (other than blood) may take up to three weeks to grow on plated media. </p><p><em>Brucella </em>organisms can survive up to two days in milk at 8°C, up to three weeks in frozen meat, and up to three months in goat cheese. <em>Brucellae</em> shed in animal excretions may remain viable for &gt;40 days if the soil is damp. The organisms are sensitive to heat, ionizing radiation, most commonly used disinfectants, and pasteurization [<a href="#rid47">47,53,54</a>].</p><p class="headingAnchor" id="H2"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H3686611602"><span class="h2">Signs and symptoms</span><span class="headingEndMark"> — </span><em>Brucellae</em> are taken up by local tissue lymphocytes, enter the circulation via regional lymph nodes, and seed throughout the body, with tropism for the reticuloendothelial system. The incubation period (from acquisition to clinical manifestations) is usually two to four weeks; occasionally, it may be as long as several months [<a href="#rid1">1,20</a>]. </p><p>Brucellosis typically presents with insidious onset of fever, malaise, night sweats (associated with a strong, peculiar, moldy odor), and arthralgias  (<a class="graphic graphic_table graphicRef121901" href="/d/graphic/121901.html" rel="external">table 3</a>) [<a href="#rid1">1,22</a>]. The fever pattern is variable; it may be spiking and accompanied by rigors, or may be relapsing, mild, or protracted. Additional symptoms may include weight loss, arthralgia, low back pain, headache, dizziness, anorexia, dyspepsia, abdominal pain, cough, and depression [<a href="#rid1">1,11</a>]. Physical findings are variable and nonspecific; hepatomegaly, splenomegaly, and/or lymphadenopathy may be observed. </p><p>The clinical manifestations of brucellosis in patients with HIV infection are the same as in patients without HIV infection [<a href="#rid55">55</a>].</p><p class="headingAnchor" id="H2498145288"><span class="h2">Complications</span><span class="headingEndMark"> — </span>Complications of brucellosis include infection involving one or more focal sites; the likelihood of focal involvement ranges from 6 to 92 percent and is usually about 30 percent [<a href="#rid22">22,56-60</a>]. Complications of brucellosis occur more frequently in adults than in children [<a href="#rid61">61,62</a>]. </p><p>Brucellosis can affect any organ system [<a href="#rid20">20</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Osteoarticular disease is the most common form of focal brucellosis; it occurs in up to 70 percent of patients with brucellosis [<a href="#rid61">61,63-65</a>]. Forms include peripheral arthritis, sacroiliitis, and spondylitis. The sacroiliac (up to 80 percent of those with osteoarticular disease) and spinal joints (up to 54 percent) are the most commonly affected sites [<a href="#rid66">66</a>]. Sacroiliitis is important manifestation in young adults [<a href="#rid64">64,67</a>]; it is unilateral in almost 80 percent of cases [<a href="#rid64">64,68,69</a>]. Peripheral arthritis and sacroiliitis occur in the context of acute disease. Peripheral arthritis usually involves the knees, hips, and ankles [<a href="#rid63">63,64,70</a>]. Prosthetic joints can also be affected. </p><p></p><p class="bulletIndent1">Spondylitis is a serious complication of brucellosis; it is more prevalent in older patients and patients with prolonged illness prior to treatment [<a href="#rid63">63</a>]. The lumbar vertebrae are involved more frequently than the thoracic and cervical vertebrae, and associated paravertebral, epidural, and psoas abscesses have been described [<a href="#rid71">71-73</a>]. Spondylitis is frequently associated with residual damage following treatment. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Genitourinary involvement is the second most common form of focal brucellosis; it occurs in up to 10 percent of cases [<a href="#rid48">48,74</a>]. In males, orchitis and/or epididymitis are the most common presentation; prostatitis and testicular abscess occur less commonly. In women, tubo-ovarian abscess has been described. Additional manifestations include cystitis, interstitial nephritis, glomerulonephritis, and renal abscess [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1">Brucellosis in pregnant women has been associated with the risk of spontaneous abortion, intrauterine fetal death, premature delivery, and intrauterine infection with possible fetal death [<a href="#rid28">28,47,75-77</a>]. In one study including more than 240 pregnant women with brucellosis, the obstetric complication rate was 14 percent; spontaneous abortion was the most common complication (6 percent of cases) [<a href="#rid77">77</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neurologic involvement occurs in up to 10 percent of cases [<a href="#rid48">48,74</a>]. Manifestations include meningitis (acute or chronic), encephalitis, brain abscess, myelitis, radiculitis, and/or neuritis (with involvement of cranial or peripheral nerves) [<a href="#rid20">20,21,47</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiovascular involvement occurs in up to 3 percent of cases [<a href="#rid48">48</a>]; it may include endocarditis, myocarditis, pericarditis, endarteritis [<a href="#rid78">78</a>], thrombophlebitis, and/or mycotic aneurysm of the aorta or ventricles. Endocarditis is the most common cardiovascular complication (1 to 2 percent of cases) and is the main cause of death attributable to brucellosis [<a href="#rid20">20,47,58</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary involvement occurs in up to 2 percent of cases [<a href="#rid48">48</a>]. Bronchitis, interstitial pneumonitis, lobar pneumonia, lung nodules, pleural effusion, hilar lymphadenopathy, empyema, or abscesses may be observed [<a href="#rid58">58,79-81</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intra-abdominal manifestations are rare; these may include hepatic or splenic abscess, cholecystitis, pancreatitis, ileitis, colitis, and peritonitis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ocular involvement is rare; uveitis is the most common form. Other manifestations include keratoconjunctivitis, corneal ulcers, iridocyclitis, nummular keratitis, choroiditis, optic neuritis, papilledema, and endophthalmitis [<a href="#rid82">82</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dermatologic manifestations occur in up to 10 percent of cases. Findings may include macular, maculopapular, scarlatiniform, papulonodular, and erythema nodosum-like eruptions, ulcerations, petechiae, purpura, granulomatous vasculitis, and abscesses [<a href="#rid47">47,58,83</a>].</p><p></p><p>In the absence of a specific definition for chronic brucellosis by the United States Centers for Disease Control and Prevention and the World Health Organization [<a href="#rid84">84</a>], clinicians typically consider patients with clinical manifestations for more than one year after the diagnosis of brucellosis is established to have chronic brucellosis [<a href="#rid11">11,85</a>]. </p><p>Patients suffering from chronic brucellosis may be divided into two categories [<a href="#rid86">86</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Those with a focal complication (such as spondylitis, osteomyelitis, tissue abscess, or uveitis) and objective evidence of infection (such as elevated antibody titers and/or recovery of <em>Brucellae</em> from blood or tissue culture)  </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Those with persistent symptoms in the absence of objective signs of infection (such as positive serology or cultures); symptoms may include malaise, psychiatric complaints (such as depression, anxiety, emotional lability), insomnia, sexual disturbances, tremor, or arthralgias </p><p></p><p class="headingAnchor" id="H2089891119"><span class="h2">Relapse</span><span class="headingEndMark"> — </span>The rate of relapse following treatment is 5 to 15 percent [<a href="#rid87">87</a>]. Relapse usually occurs within the first six months following completion of treatment, but may occur up to 12 months later [<a href="#rid88">88-90</a>]. </p><p>In a multivariate model for predicting relapse, independent predictors included temperature ≥38.3°C, duration of symptoms &lt;10 days prior to treatment, and positive blood cultures at baseline [<a href="#rid91">91</a>]. In areas with ongoing exposure, differentiation between relapse and reinfection can be difficult [<a href="#rid11">11,90,92</a>].</p><p>Causes of relapse include an inadequate antibiotic regimen, inadequate duration of antibiotic therapy, lack of adherence, or localized foci of infection [<a href="#rid63">63</a>]. Relapse may also occur in the absence of the preceding factors. Relapse due to antibiotic resistance is rare. </p><p class="headingAnchor" id="H333811203"><span class="h2">Laboratory findings</span><span class="headingEndMark"> — </span>Laboratory findings of brucellosis may include elevated transaminases and hematologic abnormalities including anemia, leukopenia or leukocytosis with relative lymphocytosis, and thrombocytopenia  (<a class="graphic graphic_table graphicRef121901" href="/d/graphic/121901.html" rel="external">table 3</a>) [<a href="#rid1">1,22,47,93,94</a>]. </p><p>In the setting of <em>Brucella </em>arthritis, the synovial fluid white blood cell count is usually ≤15,000 cells/microL (lymphocyte-predominant) [<a href="#rid95">95-98</a>]. The organism can be grown in synovial fluid [<a href="#rid68">68,98,99</a>].</p><p>In the setting of brucellosis with neurologic involvement, cerebrospinal fluid findings include a pleocytosis (10 to 200 white blood cells, predominantly mononuclear cells), mild to moderately elevated protein levels (mean 330±490 mg/dL in one study [<a href="#rid100">100</a>]), and hypoglycorrhachia [<a href="#rid101">101,102</a>]. Measurement of the cerebrospinal fluid (CSF) adenosine deaminase (ADA) level may be a useful adjunctive test for diagnosis of central nervous system brucellosis [<a href="#rid103">103</a>]. However, elevated CSF ADA levels may also be observed in the setting of tuberculosis and other infections, and there is no clear threshold to distinguish neurobrucellosis from meningitis caused by other infectious agents [<a href="#rid104">104,105</a>]. Uncommonly, the organism may be recovered in CSF culture; the yield of <em>Brucella</em> CSF culture ranges from 4 to 38 percent [<a href="#rid102">102,106,107</a>]. More frequently antibody or agglutination testing of spinal fluid may be used to establish the diagnosis [<a href="#rid102">102</a>]. </p><p>In the setting of genitourinary involvement, pyuria may be observed; the organism may be grown in urine culture [<a href="#rid108">108,109</a>]. </p><p class="headingAnchor" id="H3"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H2389366460"><span class="h2">Clinical approach</span><span class="headingEndMark"> — </span>Brucellosis should be suspected in patients with relevant signs and symptoms (fever, malaise, night sweats, and arthralgia) in the setting of relevant epidemiologic exposure (consumption of unpasteurized dairy products, animal exposure in an endemic area, and/or occupational exposure). (See <a class="local">'Epidemiology'</a> above.)</p><p>A definitive diagnosis of brucellosis may be made via either of the following [<a href="#rid3">3,98,110-112</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Culture of the organism from blood, body fluids (urine, cerebrospinal fluid, synovial fluid, and pleural fluid), or tissue (such as bone marrow or liver biopsy). However, this method is time consuming and hazardous  (<a class="graphic graphic_table graphicRef78971" href="/d/graphic/78971.html" rel="external">table 2</a>) [<a href="#rid113">113</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A fourfold or greater rise in <em>Brucella</em> antibody titer between acute and convalescent phase serum specimens obtained ≥2 weeks apart</p><p></p><p>A presumptive diagnosis of brucellosis may be made via either of the following [<a href="#rid3">3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><em>Brucella</em> total antibody titer ≥1:160 by standard tube agglutination test (SAT) in serum specimen obtained after onset of symptoms</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Detection of <em>Brucella</em> DNA in a clinical specimen by polymerase chain reaction assay </p><p></p><p class="headingAnchor" id="H2887050239"><span class="h2">Obtaining diagnostic studies</span><span class="headingEndMark"> — </span>For patients with suspected brucellosis, blood cultures and serologic testing should be performed. In addition, laboratory studies including complete blood count and liver function tests should be obtained. Laboratory workers should be informed about the diagnostic possibility of brucellosis in order to implement special culture techniques and appropriate precautions  (<a class="graphic graphic_table graphicRef78971" href="/d/graphic/78971.html" rel="external">table 2</a>). </p><p>For patients with negative blood cultures and negative serologic studies, further investigation should be guided by the clinical presentation, tailored to individual circumstances. As an example, patients with signs and symptoms of osteoarticular disease warrant synovial fluid analysis and radiographic imaging. Patients with neurologic manifestations warrant lumbar puncture; this procedure usually does not enable definitive diagnosis but may be useful to distinguish brucellosis from other causes of disease. (See <a class="local">'Laboratory findings'</a> above and <a class="local">'Imaging'</a> below.)</p><p>If the above evaluation is unrevealing, bone marrow biopsy for culture and histopathology is warranted [<a href="#rid1">1,47</a>]. If bone marrow evaluation is not diagnostic and there is evidence for liver involvement (based on liver function tests and/or radiographic imaging), liver biopsy is warranted. (See <a class="local">'Adjunctive tools'</a> below.)</p><p class="headingAnchor" id="H1757396919"><span class="h2">Diagnostic tests</span></p><p class="headingAnchor" id="H4"><span class="h3">Culture</span><span class="headingEndMark"> — </span>The sensitivity of blood culture for diagnosis of brucellosis is 15 to 70 percent [<a href="#rid114">114</a>]. Automated blood culture systems are most effective; biphasic (solid and liquid) blood culture (Ruiz-Castaneda technique) is still used in some resource-limited settings [<a href="#rid1">1</a>]. Blood cultures are often negative in the setting of chronic disease [<a href="#rid2">2</a>]. Issues related to blood cultures are discussed further above. (See <a class="local">'Laboratory identification'</a> above.)</p><p>Bone marrow culture is more sensitive than blood culture and is considered the gold standard for diagnosis of brucellosis [<a href="#rid1">1</a>]. In one study including 50 patients diagnosed with brucellosis, bone marrow culture was positive in 92 percent of cases [<a href="#rid115">115</a>]. Bone marrow culture has a shorter time to detection than blood culture, and its sensitivity is not diminished by prior antibiotic use [<a href="#rid115">115</a>]. </p><p class="headingAnchor" id="H5"><span class="h3">Serologic tests</span><span class="headingEndMark"> — </span>A variety of serologic methods that enable antibody detection against lipopolysaccharide or other antigens have been used for diagnosis of brucellosis. Serologic results must be interpreted in context of clinical presentation and epidemiologic data [<a href="#rid112">112</a>]. The most common tests are SAT and enzyme-linked immunosorbent assays (ELISAs). Additional tests include screening tests (Rose Bengal agglutination test and the immunochromatographic lateral flow assay). Tests that may be most useful for patients with complicated and/or chronic infection include the 2-mercaptoethanol (2-ME) agglutination test, the immunocapture agglutination (Brucellacapt) test, and the indirect Coombs test. </p><p>To optimize the likelihood of diagnosis, it may be useful to use a combination of two serologic tests (such as SAT with 2-ME, SAT with Brucellacapt, SAT with indirect Coombs, or ELISA for immunoglobulin [Ig]G and IgM); this approach allows antibody detection at different stages of disease. In acute disease, any of the assays may be positive; in chronic or complicated disease, SAT may be negative while 2-ME, Brucellacapt, Coombs, and ELISA IgG may be positive.</p><p>The SAT is the serologic method for which there is the greatest experience [<a href="#rid11">11,20,116</a>]. In general, positive SAT titers consist of &gt;1:160 outside endemic regions and &gt;1:320 within endemic areas [<a href="#rid1">1</a>]. Evolution of titers (eg, a fourfold or greater rise in titer between acute and convalescent phase serum specimens obtained ≥2 weeks apart) may be used as a diagnostic tool [<a href="#rid44">44</a>]; however, this definition is clinically impractical and may delay therapy. The sensitivity and specificity of SAT are high (95 and 100 percent, respectively, in one study) [<a href="#rid117">117</a>]. In patients with chronic <em>Brucella </em>infection, nonagglutinating antibodies progressively become more abundant than the agglutinating ones and the SAT may give false-negative results [<a href="#rid112">112</a>]. SAT may not be used for diagnosis of <em>B. canis</em> infection; <em>B. canis</em> serology should be requested specifically if brucellosis is suspected but the SAT is negative, or if there is clinical suspicion for <em>B. canis</em> infection [<a href="#rid50">50,118</a>]. </p><p>ELISAs measure IgM, IgG, and IgA, and typically use whole cells or sonicate, purified lipopolysaccharide (LPS), protein extracts, or other antigens [<a href="#rid48">48</a>]. In one study including more than 130 patients, the sensitivity of ELISA IgM or IgG were lower than SAT (45 and 79 versus 95 percent, respectively); when ELISA IgM and IgG were used in combination, the sensitivity and specificity were comparable with SAT (94 and 97 percent, respectively) [<a href="#rid117">117</a>]. ELISA with smooth LPS is a promising test but there are problems of interlaboratory variability; standard reference materials are needed [<a href="#rid2">2,11,110</a>]. ELISA is preferred for diagnosis of neurobrucellosis, and may be used to distinguish from other infections that give false positive serologic results due to cross reaction [<a href="#rid112">112</a>].  </p><p>Serologic tests with short turnaround time that may be used as screening tools include the Rose Bengal agglutination test (sensitivity and specificity 87 and 100 percent, respectively, in one study) [<a href="#rid119">119</a>] and the immunochromatographic lateral flow assay (sensitivity and specificity 92 and 97 percent, respectively) [<a href="#rid39">39,48,84</a>].</p><p>Serologic tests that may be useful for patients with complicated and/or chronic infection include the 2-ME agglutination test, the immunocapture agglutination (Brucellacapt) test, and the indirect Coombs test [<a href="#rid110">110,120,121</a>]. The Brucellacapt and indirect Coombs tests have similar sensitivity and specificity; the Brucellacapt is more rapid and less cumbersome to perform [<a href="#rid48">48</a>]. In one study including 82 patients with brucellosis, the specificities of the Brucellacapt, Coombs, and SAT were 81, 96, and 100 percent, respectively [<a href="#rid122">122</a>]. (See  <a class="medical medical_review" href="/d/html/121314.html" rel="external">"Brucellosis: Treatment and prevention", section on 'Limited role of follow-up serology'</a>.)</p><p>There are a number of disadvantages associated with serologic tests. Cross-reactivity with other bacteria is a problem with standard tube agglutination; cross-reacting organisms include <em>Francisella tularensis</em>, <em>Yersinia enterocolitica</em>, <em>Escherichia coli, Salmonella urbana</em>, <em>Vibrio cholerae</em>, and others [<a href="#rid1">1,123</a>]. False-negative results are common early in the course of infection, in the setting of immunosuppression, and in the presence of incomplete or blocking antibodies (serum agglutination) [<a href="#rid124">124-126</a>]. In addition, a "prozone" phenomenon (eg, inhibition of agglutination at low dilutions due to an excess of antibodies or to nonspecific serum factors) may also be observed with serum agglutination testing [<a href="#rid11">11,123</a>].</p><p>The interpretation of serologic tests can be difficult in the setting of chronic infection, reinfection, relapse, and in endemic areas where a high proportion of the population has antibodies against brucellosis [<a href="#rid80">80</a>]. Positive serologic test results can persist long after recovery in treated individuals, so it is not always possible to distinguish serologically between active and past infection [<a href="#rid110">110,120,127</a>]. </p><p>Issues related to use of serologic tests in the context of follow-up are discussed further separately. (See  <a class="medical medical_review" href="/d/html/121314.html" rel="external">"Brucellosis: Treatment and prevention", section on 'Limited role of follow-up serology'</a>.)</p><p class="headingAnchor" id="H290172860"><span class="h3">Molecular tests</span><span class="headingEndMark"> — </span>Thus far, development of molecular testing for diagnosis of brucellosis is promising, but this is not yet a routine diagnostic [<a href="#rid20">20,128-132</a>]. Molecular tests can be a valuable diagnostic method in patients with seronegative tests [<a href="#rid133">133</a>]. Positive molecular test results cannot discriminate between active disease and prior (resolved) brucellar infection [<a href="#rid132">132</a>]. All <em>Brucella</em> 16S rRNA gene sequences have been determined to be identical; therefore, 16S rRNA gene sequencing is useful for genus identification, but cannot be used for species identification [<a href="#rid131">131</a>]. </p><p>A multiplex PCR, Bruce-ladder, can identify and differentiate between <em>Brucella</em> species and vaccine strains; it can be used in epidemiologic analysis and for confirmation of relapse and laboratory-acquired infection [<a href="#rid86">86,130</a>].</p><p class="headingAnchor" id="H3541685598"><span class="h2">Adjunctive tools</span></p><p class="headingAnchor" id="H875280719"><span class="h3">Imaging</span><span class="headingEndMark"> — </span>Radiographic imaging may be useful for evaluation of patients with signs and symptoms of brucellosis, but does not enable definitive diagnosis. </p><p>For evaluation of spondylitis, magnetic resonance imaging is the preferred imaging study; other modalities include plain radiography, computed tomography (CT), and bone scintigraphy [<a href="#rid66">66,134</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>Radiographic and CT findings of brucellar spondylitis include intervertebral disk narrowing, epiphysitis of the antero-superior angle with step-like deformities (the Pons sign), osteoporosis, dense sclerosis, parrot beak osteophytes with vertebral "bridging," and interapophyseal involvement. Findings of progressive disease may include osteolysis with vertebral body destruction and abscess (paravertebral or epidural) [<a href="#rid63">63,135</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>MRI findings include decreased signal intensity in the intervertebral disc, while the adjacent vertebral bodies appear hypointense on T-1 weighted images and hyperintense on T-2 weighted images [<a href="#rid136">136,137</a>]. The radiographic findings of sacroiliitis include blurred joint margins, narrowing or widening of the joint space, subchondral erosion or sclerosis. For peripheral arthritis, these findings encompass joint space narrowing or widening, subchondral erosion, sclerosis, and soft tissue swelling [<a href="#rid63">63</a>].</p><p></p><p>For patients with brucellosis who present with fever of uncertain etiology and undergo CT scan, hepatosplenic disease with localized calcification may be observed  (<a class="graphic graphic_diagnosticimage graphicRef72028" href="/d/graphic/72028.html" rel="external">image 1</a>) [<a href="#rid138">138</a>]. </p><p>In the setting of suspected endocarditis, echocardiography should be pursued. (See  <a class="medical medical_review" href="/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a> and  <a class="medical medical_review" href="/d/html/2138.html" rel="external">"Prosthetic valve endocarditis: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H1414429833"><span class="h3">Histopathology</span><span class="headingEndMark"> — </span>Bone marrow biopsy and liver biopsy may demonstrate noncaseating granulomas (consisting of epithelioid cells, polymorphonuclear leukocytes, lymphocytes, and some giant cells) in the setting of infection due to <em>B. melitensis</em> and <em>B. abortus</em>; in <em>B. melitensis</em> infection, the granulomata are very small. <em>B. suis</em> infection is often accompanied by chronic abscess formation [<a href="#rid47">47</a>].</p><p class="headingAnchor" id="H3713284719"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Given the protean manifestations of brucellosis, the differential diagnosis varies depending on the clinical presentation. In patients with undifferentiated fever, the differential diagnosis includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Malaria – Malaria is characterized by fever, malaise, nausea, vomiting, abdominal pain, diarrhea, myalgia, and anemia. Transmission is via mosquito; the disease occurs throughout most tropical regions. The diagnosis of malaria is established by visualization of parasites on peripheral smear. (See  <a class="medical medical_review" href="/d/html/5709.html" rel="external">"Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children"</a> and  <a class="medical medical_review" href="/d/html/5707.html" rel="external">"Laboratory tools for diagnosis of malaria"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tuberculosis – Tuberculosis (TB) is characterized by cough, lymphadenopathy, fevers, night sweats, and weight loss. In addition, TB may present with extrapulmonary manifestations including musculoskeletal and central nervous system involvement. Transmission is human to human, and infection occurs worldwide. Diagnostic evaluation includes chest radiography and sputum microbiology; further investigation is tailored to clinical manifestations. (See  <a class="medical medical_review" href="/d/html/7026.html" rel="external">"Pulmonary tuberculosis: Clinical manifestations and complications"</a> and  <a class="medical medical_review" href="/d/html/111683.html" rel="external">"Diagnosis of pulmonary tuberculosis in adults"</a> and  <a class="medical medical_review" href="/d/html/7658.html" rel="external">"Bone and joint tuberculosis"</a> and  <a class="medical medical_review" href="/d/html/8009.html" rel="external">"Central nervous system tuberculosis: An overview"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Visceral leishmaniasis – Visceral leishmaniasis is characterized by subacute progression of malaise, fever, weight loss, and splenomegaly (with or without hepatomegaly) over a period of months. Transmission occurs via sand fly bites, and endemic areas include the Mediterranean, the Middle East, Afghanistan, Iran, Pakistan, East Africa, India, Nepal, Bangladesh, and Brazil. The diagnosis is established by histopathology, culture, or serology. (See  <a class="medical medical_review" href="/d/html/5732.html" rel="external">"Visceral leishmaniasis: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Endocarditis – Endocarditis is characterized by fever, often associated with chills, anorexia, and weight loss. Other common symptoms include malaise, headache, myalgias, arthralgias, night sweats, abdominal pain, and dyspnea. The diagnosis is established based on clinical manifestations, blood cultures (or other microbiologic data), and echocardiography. (See  <a class="medical medical_review" href="/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HIV infection – Acute HIV infection is commonly characterized by fever, lymphadenopathy, sore throat, rash, myalgia/arthralgia, and headache. The infection is transmitted sexually, and infection occurs worldwide. The diagnosis is established via immunoassay and viral load. (See  <a class="medical medical_review" href="/d/html/86984.html" rel="external">"Acute and early HIV infection: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Enteric fever – Enteric fever (caused by <em>Salmonella enterica</em> serotype Typhi [formerly <em>Salmonella typhi</em>] and <em>S. enterica</em> serovar Paratyphi A, B, and C) is characterized by abdominal pain, fever, and chills. Classic manifestations include relative bradycardia, pulse-temperature dissociation, and "rose spots" (faint macules on the trunk and abdomen). Hepatosplenomegaly, intestinal bleeding, and perforation may occur, leading to secondary bacteremia and peritonitis. The disease occurs worldwide; regions of highest incidence include South Asia, Southeast Asia, and southern Africa. Transmission is fecal-oral. The diagnosis is established via culture. (See  <a class="medical medical_review" href="/d/html/2708.html" rel="external">"Enteric (typhoid and paratyphoid) fever: Epidemiology, clinical manifestations, and diagnosis"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Q fever – Q fever is a zoonotic infection caused by <em>Coxiella burnetii. </em>Clinical manifestations include flu-like illness, pneumonia, granulomatous hepatitis, and endocarditis. Q fever is mainly occupational disease that may occur through inhalation of contaminated aerosols or intradermal inoculation. The diagnosis is established via serology and polymerase chain reaction. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Malignancy – The most common malignancies presenting with fever of unknown origin include lymphoma, leukemia, renal cell carcinoma and hepatocellular carcinoma, or other tumors metastatic to the liver. (See  <a class="medical medical_review" href="/d/html/2737.html" rel="external">"Fever of unknown origin in adults: Etiologies", section on 'Malignancies'</a>.)</p><p></p><p>In patients with osteoarticular manifestations, additional diagnostic considerations include:</p><p class="bulletIndent1"><span class="glyph">●</span>Spondyloarthritis – Spondyloarthritis refers to a group of diseases that share clinical features including chronic low back pain, heel enthesitis, dactylitis, and oligoarthritis. The diagnosis is established based on clinical manifestations, radiographic findings, and laboratory tests. (See  <a class="medical medical_review" href="/d/html/95962.html" rel="external">"Overview of the clinical manifestations and classification of spondyloarthritis"</a> and  <a class="medical medical_review" href="/d/html/7786.html" rel="external">"Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reactive arthritis – Reactive arthritis is a form of arthritis associated with a coexisting or recent antecedent extra-articular infection. Enteric and genitourinary pathogens capable of causing reactive arthritis include <em>Chlamydia trachomatis</em>, <em>Yersinia</em>, <em>Salmonella</em>, <em>Shigella</em>, <em>Campylobacter</em>, <em>Clostridioides difficile</em>, and <em>Chlamydia pneumoniae</em>. Synovial fluid findings are similar to those seen in patients with arthritis associated with brucellosis. The diagnosis is based on clinical presentation and exclusion of other causes. (See  <a class="medical medical_review" href="/d/html/7794.html" rel="external">"Reactive arthritis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Septic arthritis – Septic arthritis refers to infection in a joint; it is usually caused by bacteria but can also be caused by other microorganisms. Most commonly, septic arthritis arises via hematogenous seeding; it may also develop as a result of direct inoculation of bacteria into the joint. Rarely, septic arthritis develops via extension of infection into the joint space from adjacent tissues. The diagnosis is established based on synovial fluid analysis and culture. (See  <a class="medical medical_review" href="/d/html/7666.html" rel="external">"Septic arthritis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lyme disease – Lyme disease is caused by <em>Borrelia burgdorferi. </em>In late disease, clinical manifestations may include intermittent or persistent arthritis of the large joints. The diagnosis is suspected based clinical presentation and tick exposure; it is confirmed via serology and/or polymerase chain reaction. (See  <a class="medical medical_review" href="/d/html/7913.html" rel="external">"Clinical manifestations of Lyme disease in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Viral infections – Viral infections may cause arthritis, fever, and other constitutional manifestations; agents include chikungunya fever virus, rubella, parvovirus B19, hepatitis B virus, and others. The diagnosis is established via serology and polymerase chain reaction. (See  <a class="medical medical_review" href="/d/html/5614.html" rel="external">"Viral arthritis: Causes and approach to evaluation and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Systemic lupus erythematosus – Systemic lupus erythematosus is characterized by fever, rash, and inflammatory polyarthritis or arthralgias. The diagnosis is established via presence of antinuclear antibodies and other characteristic systemic manifestations. (See  <a class="medical medical_review" href="/d/html/4668.html" rel="external">"Clinical manifestations and diagnosis of systemic lupus erythematosus in adults"</a>.)</p><p></p><p class="bulletIndent1">Rheumatoid arthritis – Rheumatoid arthritis is a symmetric, inflammatory, peripheral polyarthritis involving peripheral joints; extra-articular features may include anemia, fatigue, subcutaneous nodules, pleuropericarditis, parenchymal lung diseases, neuropathy, and renal involvement. The diagnosis can be made via clinical criteria and laboratory and serologic tests. (See  <a class="medical medical_review" href="/d/html/7502.html" rel="external">"Clinical manifestations of rheumatoid arthritis"</a> and  <a class="medical medical_review" href="/d/html/7504.html" rel="external">"Diagnosis and differential diagnosis of rheumatoid arthritis"</a>.)</p><p></p><p>In patients with biopsy demonstrating noncaseating granulomas, the differential diagnosis includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Sarcoidosis – Sarcoidosis is a multisystem disorder of unknown etiology; it most frequently involves the lung but can involve all organ systems. The diagnosis requires compatible clinical and radiographic manifestations, exclusion of other diseases that may present similarly, and histopathologic detection of noncaseating granulomas. (See  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis"</a> and  <a class="medical medical_review" href="/d/html/91259.html" rel="external">"Overview of extrapulmonary manifestations of sarcoidosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fungal infection – Fungal infections (eg, histoplasmosis, blastomycosis) may be associated with granulomatous disease. In the setting of suspected fungal infection, biopsy specimens should be evaluated with fungal stains and culture. In the setting of relevant epidemiologic exposure for histoplasmosis, urine and serum antigen testing should also be performed. (See  <a class="medical medical_review" href="/d/html/2451.html" rel="external">"Diagnosis and treatment of pulmonary histoplasmosis"</a> and  <a class="medical medical_review" href="/d/html/2437.html" rel="external">"Clinical manifestations and diagnosis of blastomycosis"</a>.)</p><p></p><p class="headingAnchor" id="H20"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General principles</strong> – Brucellosis is a zoonotic infection transmitted to humans from infected animals (cattle, sheep, goats, camels, pigs, or other animals) by ingestion of food products (such as unpasteurized dairy products) or by contact with tissue or fluids. It is the most common zoonosis worldwide and is an important public health problem in many resource-limited settings. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Endemic areas for brucellosis include countries of the Mediterranean basin, Middle East, Central Asia, China, the Indian subcontinent, sub-Saharan Africa, and parts of Mexico and Central and South America  (<a class="graphic graphic_table graphicRef121902" href="/d/graphic/121902.html" rel="external">table 1</a>). Worldwide, approximately 500,000 cases are reported annually. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transmission</strong> – The most common mechanisms for transmission of brucellosis to humans are consumption of infected, unpasteurized animal products, contact of skin or mucous membranes with infected animal tissue (such as placenta or miscarriage products) or infected animal fluids (such as blood, urine, or milk), and inhalation of infected aerosolized particles. Laboratory workers should be informed about the diagnostic possibility of brucellosis in order to implement special culture techniques and appropriate precautions  (<a class="graphic graphic_table graphicRef78971" href="/d/graphic/78971.html" rel="external">table 2</a>). (See <a class="local">'Transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – (See <a class="local">'Clinical manifestations'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Signs and symptoms</strong> – The incubation period is usually two to four weeks; occasionally, it may be as long as several months. Brucellosis typically presents with insidious onset of fever, malaise, night sweats (associated with a strong, peculiar, moldy odor), and arthralgias  (<a class="graphic graphic_table graphicRef121901" href="/d/graphic/121901.html" rel="external">table 3</a>). Physical findings are variable and nonspecific; hepatomegaly, splenomegaly, and/or lymphadenopathy may be observed. Laboratory findings of brucellosis may include elevated transaminases and hematologic abnormalities including anemia, leukopenia or leukocytosis with relative lymphocytosis, and thrombocytopenia. (See <a class="local">'Signs and symptoms'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Complications</strong> – Complications of brucellosis include infection involving one or more focal sites; any organ system can be affected. Osteoarticular disease is the most common form of focal brucellosis; it occurs in up to 70 percent of patients with brucellosis. (See <a class="local">'Complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical approach</strong> – Brucellosis should be suspected in patients with relevant signs and symptoms (fever, malaise, night sweats, and arthralgia) in the setting of relevant epidemiologic exposure (consumption of unpasteurized dairy products, animal exposure in an endemic area, and/or occupational exposure). A definitive diagnosis may be made by culture of the organism (from blood, body fluids, or tissue), or ≥4-fold rise in <em>Brucella</em> antibody titer between acute and convalescent phase serum specimens obtained ≥2 weeks apart. A presumptive diagnosis may be made by antibody titer ≥1:160 via standard tube agglutination test or by polymerase chain reaction detection of <em>Brucella</em> DNA in a clinical specimen. (See <a class="local">'Clinical approach'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Obtaining diagnostic studies</strong> – For patients with suspected brucellosis, blood cultures and serologic testing should be performed. In addition, laboratory studies including complete blood count and liver function tests should be obtained. For patients with negative blood cultures and negative serologic studies, further investigation should be guided by the clinical presentation, tailored to individual circumstances. (See <a class="local">'Obtaining diagnostic studies'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005; 352:2325.</a></li><li class="breakAll">WHO/CDS/EPR/2006.7. Brucellosis in humans and animals Geneva: World Health Organization, 2006.</li><li class="breakAll">Centers for Disease Control (CDC) Brucellosis Reference Guide 2017. https://www.cdc.gov/brucellosis/pdf/brucellosi-reference-guide.pdf (Accessed on May 23, 2019).</li><li><a class="nounderline abstract_t">Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human brucellosis. Lancet Infect Dis 2006; 6:91.</a></li><li><a class="nounderline abstract_t">Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis. Vet Microbiol 2010; 140:392.</a></li><li><a class="nounderline abstract_t">Bosilkovski M, Dimzova M, Grozdanovski K. Natural history of brucellosis in an endemic region in different time periods. Acta Clin Croat 2009; 48:41.</a></li><li><a class="nounderline abstract_t">Jennings GJ, Hajjeh RA, Girgis FY, et al. Brucellosis as a cause of acute febrile illness in Egypt. Trans R Soc Trop Med Hyg 2007; 101:707.</a></li><li><a class="nounderline abstract_t">Greenfield RA, Drevets DA, Machado LJ, et al. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci 2002; 323:299.</a></li><li><a class="nounderline abstract_t">Pappas G, Panagopoulou P, Christou L, Akritidis N. Brucella as a biological weapon. Cell Mol Life Sci 2006; 63:2229.</a></li><li><a class="nounderline abstract_t">Hull NC, Schumaker BA. Comparisons of brucellosis between human and veterinary medicine. Infect Ecol Epidemiol 2018; 8:1500846.</a></li><li><a class="nounderline abstract_t">Young EJ. Brucellosis: current epidemiology, diagnosis, and management. Curr Clin Top Infect Dis 1995; 15:115.</a></li><li class="breakAll">Centers for Disease Control and Prevention. CDC and Texas Health Officials Warn About Illness Linked to Raw Milk from Texas Dairy, September 17, 2017. https://www.cdc.gov/media/releases/2017/p0915-raw-milk-brucella.html (Accessed on September 18, 2017).</li><li class="breakAll">Centers for Disease Control and Prevention. Exposure to RB51 through Raw Milk or Milk Products: How to Reduce Risk of Infection. https://www.cdc.gov/brucellosis/clinicians/rb51-raw-milk.html (Accessed on September 18, 2017).</li><li class="breakAll">Centers for Disease Control and Prevention. People in Four States May Be Drinking Contaminated Raw Milk, November 21, 2017. http://www.cdc.gov/media/releases/2017/p1121-contaminated-raw-milk.html (Accessed on November 28, 2017).</li><li><a class="nounderline abstract_t">White PJ, Treanor JJ, Geremia C, et al. Bovine brucellosis in wildlife: using adaptive management to improve understanding, technology and suppression. Rev Sci Tech 2013; 32:263.</a></li><li><a class="nounderline abstract_t">Eales KM, Norton RE, Ketheesan N. Brucellosis in northern Australia. Am J Trop Med Hyg 2010; 83:876.</a></li><li><a class="nounderline abstract_t">Robson JM, Harrison MW, Wood RN, et al. Brucellosis: re-emergence and changing epidemiology in Queensland. Med J Aust 1993; 159:153.</a></li><li class="breakAll">Salvana EMT, Salata RA. Brucellosis. In: Goldman-Cecil Medicine, 25th ed, Goldman L, Schafer AI (Eds), Elsevier, Philadelphia 2015. p.1979.</li><li><a class="nounderline abstract_t">Olsen SC, Tatum FM. Swine brucellosis: current perspectives. Vet Med (Auckl) 2017; 8:1.</a></li><li><a class="nounderline abstract_t">Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol 2007; 25:188.</a></li><li><a class="nounderline abstract_t">Bosilkovski M, Krteva L, Dimzova M, Kondova I. Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, laboratory test results, and therapy outcome. Int J Infect Dis 2007; 11:342.</a></li><li><a class="nounderline abstract_t">Bosilkovski M, Krteva L, Dimzova M, et al. Human brucellosis in Macedonia - 10 years of clinical experience in endemic region. Croat Med J 2010; 51:327.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Third Case of Rifampin/Penicillin-Resistant Strain of RB51 Brucella from Consuming Raw Milk. https://emergency.cdc.gov/han/han00417.asp (Accessed on January 25, 2019).</li><li><a class="nounderline abstract_t">Poulou A, Markou F, Xipolitos I, Skandalakis PN. A rare case of Brucella melitensis infection in an obstetrician during the delivery of a transplacentally infected infant. J Infect 2006; 53:e39.</a></li><li><a class="nounderline abstract_t">Mesner O, Riesenberg K, Biliar N, et al. The many faces of human-to-human transmission of brucellosis: congenital infection and outbreak of nosocomial disease related to an unrecognized clinical case. Clin Infect Dis 2007; 45:e135.</a></li><li><a class="nounderline abstract_t">Mantur BG, Mangalgi SS, Mulimani M. Brucella melitensis--a sexually transmissible agent? Lancet 1996; 347:1763.</a></li><li><a class="nounderline abstract_t">Wang W, Liao Q, Wu X, et al. Potential risk of blood transfusion-transmitted brucellosis in an endemic area of China. Transfusion 2015; 55:586.</a></li><li><a class="nounderline abstract_t">Bosilkovski M, Arapović J, Keramat F. Human brucellosis in pregnancy - an overview. Bosn J Basic Med Sci 2020; 20:415.</a></li><li class="breakAll">Alton GG, Jones LM, Angus RD, Verger JM. Techniques for the brucellosis laboratory, Institut National de la recherche Agronomique, Paris 1988.</li><li class="breakAll">Wright SG. Brucellosis. In: Hunter’s Tropical Medicine and Emerging Infectious Diseases, 8th ed, Strickland GT (Ed), W.B. Saunders Company, Philadelphia 2000. p.416.</li><li><a class="nounderline abstract_t">Troy SB, Rickman LS, Davis CE. Brucellosis in San Diego: epidemiology and species-related differences in acute clinical presentations. Medicine (Baltimore) 2005; 84:174.</a></li><li><a class="nounderline abstract_t">Young EJ. An overview of human brucellosis. Clin Infect Dis 1995; 21:283.</a></li><li><a class="nounderline abstract_t">Kolwijck E, Lutgens SPM, Visser VXN, et al. First Case of Human Brucella canis Infection in the Netherlands. Clin Infect Dis 2022; 75:2250.</a></li><li><a class="nounderline abstract_t">Dokuzoğuz B, Ergönül O, Baykam N, et al. Characteristics of B. melitensis versus B. abortus bacteraemias. J Infect 2005; 50:41.</a></li><li><a class="nounderline abstract_t">Sohn AH, Probert WS, Glaser CA, et al. Human neurobrucellosis with intracerebral granuloma caused by a marine mammal Brucella spp. Emerg Infect Dis 2003; 9:485.</a></li><li><a class="nounderline abstract_t">McDonald WL, Jamaludin R, Mackereth G, et al. Characterization of a Brucella sp. strain as a marine-mammal type despite isolation from a patient with spinal osteomyelitis in New Zealand. J Clin Microbiol 2006; 44:4363.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Human exposures to marine Brucella isolated from a harbor porpoise - Maine, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:461.</a></li><li><a class="nounderline abstract_t">Pappas G. The changing Brucella ecology: novel reservoirs, new threats. Int J Antimicrob Agents 2010; 36 Suppl 1:S8.</a></li><li><a class="nounderline abstract_t">Al Dahouk S, Nöckler K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther 2011; 9:833.</a></li><li><a class="nounderline abstract_t">Whatmore AM, Davison N, Cloeckaert A, et al. Brucella papionis sp. nov., isolated from baboons (Papio spp.). Int J Syst Evol Microbiol 2014; 64:4120.</a></li><li><a class="nounderline abstract_t">Scholz HC, Revilla-Fernández S, Dahouk SA, et al. Brucella vulpis sp. nov., isolated from mandibular lymph nodes of red foxes (Vulpes vulpes). Int J Syst Evol Microbiol 2016; 66:2090.</a></li><li><a class="nounderline abstract_t">Suárez-Esquivel M, Ruiz-Villalobos N, Jiménez-Rojas C, et al. Brucella neotomae Infection in Humans, Costa Rica. Emerg Infect Dis 2017; 23:997.</a></li><li><a class="nounderline abstract_t">Li SY, Huang YE, Chen JY, et al. Genomics of Ochrobactrum pseudogrignonense (newly named Brucella pseudogrignonensis) reveals a new blaOXA subgroup. Microb Genom 2021; 7.</a></li><li><a class="nounderline abstract_t">Godfroid J, Cloeckaert A, Liautard JP, et al. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res 2005; 36:313.</a></li><li><a class="nounderline abstract_t">Al Dahouk S, Nöckler K, Tomaso H, et al. Seroprevalence of brucellosis, tularemia, and yersiniosis in wild boars (Sus scrofa) from north-eastern Germany. J Vet Med B Infect Dis Vet Public Health 2005; 52:444.</a></li><li class="breakAll">Lindquist D, Chu MC, Probert WWS. Francisella and Brucella. In: Manual of Clinical Microbiology, 9th ed, Murray PR, Baron EJO, Jorgensen JH, et al (Eds), ASM Press, Washington, DC 2007. p.824.</li><li><a class="nounderline abstract_t">Doganay M, Aygen B. Human brucellosis: An overview. Int J Infect Dis 2003; 7:173.</a></li><li><a class="nounderline abstract_t">Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents 2010; 36 Suppl 1:S12.</a></li><li><a class="nounderline abstract_t">Araj GF, Lulu AR, Mustafa MY, Khateeb MI. Evaluation of ELISA in the diagnosis of acute and chronic brucellosis in human beings. J Hyg (Lond) 1986; 97:457.</a></li><li><a class="nounderline abstract_t">Araj GF. Human brucellosis: a classical infectious disease with persistent diagnostic challenges. Clin Lab Sci 1999; 12:207.</a></li><li><a class="nounderline abstract_t">Ozturk R, Mert A, Kocak F, et al. The diagnosis of brucellosis by use of BACTEC 9240 blood culture system. Diagn Microbiol Infect Dis 2002; 44:133.</a></li><li><a class="nounderline abstract_t">Yagupsky P. Detection of Brucellae in blood cultures. J Clin Microbiol 1999; 37:3437.</a></li><li class="breakAll">Corbel MJ. Overview. In: Brucellosis, Madkuor MM (Ed), Butterworths, University Press, Cambridge (UK) 1989. p.71.</li><li class="breakAll">Corbel MJ. Microbiology of the genus Brucella. In: Brucellosis: Clinical and Laboratory Aspects, Young EJ, Corbel MJ (Eds), CRC Press, Boca Raton 1989. p.53.</li><li><a class="nounderline abstract_t">Moreno S, Ariza J, Espinosa FJ, et al. Brucellosis in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1998; 17:319.</a></li><li><a class="nounderline abstract_t">Guler S, Kokoglu OF, Ucmak H, et al. Human brucellosis in Turkey: different clinical presentations. J Infect Dev Ctries 2014; 8:581.</a></li><li><a class="nounderline abstract_t">Shi Y, Gao H, Pappas G, et al. Clinical features of 2041 human brucellosis cases in China. PLoS One 2018; 13:e0205500.</a></li><li><a class="nounderline abstract_t">Colmenero JD, Reguera JM, Martos F, et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 1996; 75:195.</a></li><li><a class="nounderline abstract_t">Aygen B, Doganay M, Sumerkan B, et al. Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients. Med Malad Infect 2002; 32:485.</a></li><li><a class="nounderline abstract_t">Hasanjani Roushan MR, Mohrez M, Smailnejad Gangi SM, et al. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiol Infect 2004; 132:1109.</a></li><li><a class="nounderline abstract_t">Shaalan MA, Memish ZA, Mahmoud SA, et al. Brucellosis in children: clinical observations in 115 cases. Int J Infect Dis 2002; 6:182.</a></li><li><a class="nounderline abstract_t">Bukhari EE. Pediatric brucellosis. An update review for the new millennium. Saudi Med J 2018; 39:336.</a></li><li><a class="nounderline abstract_t">Bosilkovski M, Krteva L, Caparoska S, Dimzova M. Osteoarticular involvement in brucellosis: study of 196 cases in the Republic of Macedonia. Croat Med J 2004; 45:727.</a></li><li><a class="nounderline abstract_t">Geyik MF, Gür A, Nas K, et al. Musculoskeletal involvement of brucellosis in different age groups: a study of 195 cases. Swiss Med Wkly 2002; 132:98.</a></li><li><a class="nounderline abstract_t">Bosilkovski M, Kirova-Urosevic V, Cekovska Z, et al. Osteoarticular involvement in childhood brucellosis: experience with 133 cases in an endemic region. Pediatr Infect Dis J 2013; 32:815.</a></li><li><a class="nounderline abstract_t">Esmaeilnejad-Ganji SM, Esmaeilnejad-Ganji SMR. Osteoarticular manifestations of human brucellosis: A review. World J Orthop 2019; 10:54.</a></li><li><a class="nounderline abstract_t">Hizel K, Guzel O, Dizbay M, et al. Age and duration of disease as factors affecting clinical findings and sacroiliitis in brucellosis. Infection 2007; 35:434.</a></li><li><a class="nounderline abstract_t">Gotuzzo E, Alarcón GS, Bocanegra TS, et al. Articular involvement in human brucellosis: a retrospective analysis of 304 cases. Semin Arthritis Rheum 1982; 12:245.</a></li><li><a class="nounderline abstract_t">Ariza J, Pujol M, Valverde J, et al. Brucellar sacroiliitis: findings in 63 episodes and current relevance. Clin Infect Dis 1993; 16:761.</a></li><li><a class="nounderline abstract_t">Hashemi SH, Keramat F, Ranjbar M, et al. Osteoarticular complications of brucellosis in Hamedan, an endemic area in the west of Iran. Int J Infect Dis 2007; 11:496.</a></li><li><a class="nounderline abstract_t">Colmenero JD, Ruiz-Mesa JD, Plata A, et al. Clinical findings, therapeutic approach, and outcome of brucellar vertebral osteomyelitis. Clin Infect Dis 2008; 46:426.</a></li><li><a class="nounderline abstract_t">Mousa AM, Bahar RH, Araj GF, et al. Neurological complications of brucella spondylitis. Acta Neurol Scand 1990; 81:16.</a></li><li><a class="nounderline abstract_t">Solera J, Lozano E, Martínez-Alfaro E, et al. Brucellar spondylitis: review of 35 cases and literature survey. Clin Infect Dis 1999; 29:1440.</a></li><li><a class="nounderline abstract_t">Artuk HC. Complications and treatment of brucellosis: 11-year results. Acta Medica Mediterranea 2019; 35:1131.</a></li><li><a class="nounderline abstract_t">Vilchez G, Espinoza M, D'Onadio G, et al. Brucellosis in pregnancy: clinical aspects and obstetric outcomes. Int J Infect Dis 2015; 38:95.</a></li><li><a class="nounderline abstract_t">Khan MY, Mah MW, Memish ZA. Brucellosis in pregnant women. Clin Infect Dis 2001; 32:1172.</a></li><li><a class="nounderline abstract_t">Inan A, Erdem H, Elaldi N, et al. Brucellosis in pregnancy: results of multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis 2019; 38:1261.</a></li><li><a class="nounderline abstract_t">Herrick JA, Lederman RJ, Sullivan B, et al. Brucella arteritis: clinical manifestations, treatment, and prognosis. Lancet Infect Dis 2014; 14:520.</a></li><li><a class="nounderline abstract_t">Pappas G, Bosilkovski M, Akritidis N, et al. Brucellosis and the respiratory system. Clin Infect Dis 2003; 37:e95.</a></li><li><a class="nounderline abstract_t">Mantur BG, Biradar MS, Bidri RC, et al. Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years' experience in an endemic area. J Med Microbiol 2006; 55:897.</a></li><li><a class="nounderline abstract_t">Erdem H, Inan A, Elaldi N, et al. Respiratory system involvement in brucellosis: the results of the Kardelen study. Chest 2014; 145:87.</a></li><li><a class="nounderline abstract_t">Rolando I, Olarte L, Vilchez G, et al. Ocular manifestations associated with brucellosis: a 26-year experience in Peru. Clin Infect Dis 2008; 46:1338.</a></li><li><a class="nounderline abstract_t">Ariza J, Servitje O, Pallarés R, et al. Characteristic cutaneous lesions in patients with brucellosis. Arch Dermatol 1989; 125:380.</a></li><li><a class="nounderline abstract_t">Rubach MP, Halliday JE, Cleaveland S, Crump JA. Brucellosis in low-income and middle-income countries. Curr Opin Infect Dis 2013; 26:404.</a></li><li><a class="nounderline abstract_t">SPINK WW. What is chronic brucellosis? Ann Intern Med 1951; 35:358.</a></li><li class="breakAll">Bosilkovski M. Brucellosis: It is not only Malta!. In: Zoonoses - Infections affecting humans and animals. Focus on public health aspects., Sing A (Ed), Springer, 2014. p.287.</li><li><a class="nounderline abstract_t">Ariza J, Bosilkovski M, Cascio A, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 2007; 4:e317.</a></li><li><a class="nounderline abstract_t">Ariza J, Corredoira J, Pallares R, et al. Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis 1995; 20:1241.</a></li><li><a class="nounderline abstract_t">Roushan MR, Gangi SM, Ahmadi SA. Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis. Swiss Med Wkly 2004; 134:564.</a></li><li><a class="nounderline abstract_t">Solera J, Martínez-Alfaro E, Espinosa A. Recognition and optimum treatment of brucellosis. Drugs 1997; 53:245.</a></li><li><a class="nounderline abstract_t">Solera J, Martínez-Alfaro E, Espinosa A, et al. Multivariate model for predicting relapse in human brucellosis. J Infect 1998; 36:85.</a></li><li class="breakAll">Gotuzzo E, Carillo C. Brucella. In: Infectious Diseases, 3rd Ed, Gorbach SL, Bartlett JG, Blacklow NR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2004. p.1717.</li><li><a class="nounderline abstract_t">al-Eissa YA, Assuhaimi SA, al-Fawaz IM, et al. Pancytopenia in children with brucellosis: clinical manifestations and bone marrow findings. Acta Haematol 1993; 89:132.</a></li><li><a class="nounderline abstract_t">Karakukcu M, Patiroglu T, Ozdemir MA, et al. Pancytopenia, a rare hematologic manifestation of brucellosis in children. J Pediatr Hematol Oncol 2004; 26:803.</a></li><li><a class="nounderline abstract_t">Sommers H M. The microbiology laboratory in the diagnosis of infectious arthritis. Clin Rhemn Dis 1978; 4:63.</a></li><li><a class="nounderline abstract_t">Goldenberg DL, Reed JI. Bacterial arthritis. N Engl J Med 1985; 312:764.</a></li><li><a class="nounderline abstract_t">Julkunen H. Reactive arthritis. Bull Rheum Dis 1979; 29:1002.</a></li><li><a class="nounderline abstract_t">Andonopoulos AP, Asimakopoulos G, Anastasiou E, Bassaris HP. Brucella arthritis. Scand J Rheumatol 1986; 15:377.</a></li><li><a class="nounderline abstract_t">al-Eissa YA, Kambal AM, Alrabeeah AA, et al. Osteoarticular brucellosis in children. Ann Rheum Dis 1990; 49:896.</a></li><li><a class="nounderline abstract_t">Erdem H, Kilic S, Sener B, et al. Diagnosis of chronic brucellar meningitis and meningoencephalitis: the results of the Istanbul-2 study. Clin Microbiol Infect 2013; 19:E80.</a></li><li><a class="nounderline abstract_t">al Deeb SM, Yaqub BA, Sharif HS, Phadke JG. Neurobrucellosis: clinical characteristics, diagnosis, and outcome. Neurology 1989; 39:498.</a></li><li><a class="nounderline abstract_t">Guven T, Ugurlu K, Ergonul O, et al. Neurobrucellosis: clinical and diagnostic features. Clin Infect Dis 2013; 56:1407.</a></li><li><a class="nounderline abstract_t">López-Cortés LF, Cruz-Ruiz M, Gómez-Mateos J, et al. Adenosine deaminase activity in the CSF of patients with aseptic meningitis: utility in the diagnosis of tuberculous meningitis or neurobrucellosis. Clin Infect Dis 1995; 20:525.</a></li><li><a class="nounderline abstract_t">Parra-Ruiz J, Ramos V, Dueñas C, et al. Rational application of adenosine deaminase activity in cerebrospinal fluid for the diagnosis of tuberculous meningitis. Infection 2015; 43:531.</a></li><li><a class="nounderline abstract_t">Sun Q, Sha W, Xiao HP, et al. Evaluation of cerebrospinal fluid adenosine deaminase activity for the differential diagnosis of tuberculous and nontuberculous meningitis. Am J Med Sci 2012; 344:116.</a></li><li><a class="nounderline abstract_t">Tajerian A, Sofian M, Zarinfar N, Ramezani A. Manifestations, complications, and treatment of neurobrucellosis: a systematic review and meta-analysis. Int J Neurosci 2022; :1.</a></li><li><a class="nounderline abstract_t">Naderi H, Sheybani F, Parsa A, et al. Neurobrucellosis: report of 54 cases. Trop Med Health 2022; 50:77.</a></li><li><a class="nounderline abstract_t">Conkar S, Kosker M, Cevik S, Ay M. Association of brucellosis with renal tubular and glomerular damage in children in Turkey. Saudi J Kidney Dis Transpl 2018; 29:284.</a></li><li><a class="nounderline abstract_t">Demiroğlu YZ, Turunç T, Alişkan H, et al. [Brucellosis: retrospective evaluation of the clinical, laboratory and epidemiological features of 151 cases]. Mikrobiyol Bul 2007; 41:517.</a></li><li><a class="nounderline abstract_t">Al Dahouk S, Tomaso H, Nöckler K, et al. Laboratory-based diagnosis of brucellosis--a review of the literature. Part II: serological tests for brucellosis. Clin Lab 2003; 49:577.</a></li><li><a class="nounderline abstract_t">Mantecón Mde L, Gutiérrez MP, Zarzosa Mdel P, et al. Influence of brucellosis history on serological diagnosis and evolution of patients with acute brucellosis. J Infect 2008; 57:397.</a></li><li><a class="nounderline abstract_t">Yagupsky P, Morata P, Colmenero JD. Laboratory Diagnosis of Human Brucellosis. Clin Microbiol Rev 2019; 33.</a></li><li><a class="nounderline abstract_t">Saddique A, Ali S, Akhter S, et al. Acute Febrile Illness Caused by Brucella abortus Infection in Humans in Pakistan. Int J Environ Res Public Health 2019; 16.</a></li><li><a class="nounderline abstract_t">Memish Z, Mah MW, Al Mahmoud S, et al. Brucella bacteraemia: clinical and laboratory observations in 160 patients. J Infect 2000; 40:59.</a></li><li><a class="nounderline abstract_t">Gotuzzo E, Carrillo C, Guerra J, Llosa L. An evaluation of diagnostic methods for brucellosis--the value of bone marrow culture. J Infect Dis 1986; 153:122.</a></li><li><a class="nounderline abstract_t">Mert A, Ozaras R, Tabak F, et al. The sensitivity and specificity of Brucella agglutination tests. Diagn Microbiol Infect Dis 2003; 46:241.</a></li><li><a class="nounderline abstract_t">Memish ZA, Almuneef M, Mah MW, et al. Comparison of the Brucella Standard Agglutination Test with the ELISA IgG and IgM in patients with Brucella bacteremia. Diagn Microbiol Infect Dis 2002; 44:129.</a></li><li><a class="nounderline abstract_t">Young EJ. Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. Rev Infect Dis 1991; 13:359.</a></li><li><a class="nounderline abstract_t">Díaz R, Casanova A, Ariza J, Moriyón I. The Rose Bengal Test in human brucellosis: a neglected test for the diagnosis of a neglected disease. PLoS Negl Trop Dis 2011; 5:e950.</a></li><li><a class="nounderline abstract_t">Bosilkovski M, Katerina S, Zaklina S, Ivan V. The role of Brucellacapt test for follow-up patients with brucellosis. Comp Immunol Microbiol Infect Dis 2010; 33:435.</a></li><li><a class="nounderline abstract_t">Roushan MR, Amiri MJ, Laly A, et al. Follow-up standard agglutination and 2-mercaptoethanol tests in 175 clinically cured cases of human brucellosis. Int J Infect Dis 2010; 14:e250.</a></li><li><a class="nounderline abstract_t">Orduña A, Almaraz A, Prado A, et al. Evaluation of an immunocapture-agglutination test (Brucellacapt) for serodiagnosis of human brucellosis. J Clin Microbiol 2000; 38:4000.</a></li><li><a class="nounderline abstract_t">Young EJ. Human brucellosis. Rev Infect Dis 1983; 5:821.</a></li><li><a class="nounderline abstract_t">Gad El-Rab MO, Kambal AM. Evaluation of a Brucella enzyme immunoassay test (ELISA) in comparison with bacteriological culture and agglutination. J Infect 1998; 36:197.</a></li><li><a class="nounderline abstract_t">ZINNEMAN HH, GLENCHUR H, HALL WH. The nature of blocking antibodies in human brucellosis. J Immunol 1959; 83:206.</a></li><li><a class="nounderline abstract_t">Wilkinson PC. Immunoglobulin patterns of antibodies against Brucella in man and animals. J Immunol 1966; 96:457.</a></li><li><a class="nounderline abstract_t">Gazapo E, Gonzalez Lahoz J, Subiza JL, et al. Changes in IgM and IgG antibody concentrations in brucellosis over time: importance for diagnosis and follow-up. J Infect Dis 1989; 159:219.</a></li><li><a class="nounderline abstract_t">Morata P, Queipo-Ortuño MI, Reguera JM, et al. Development and evaluation of a PCR-enzyme-linked immunosorbent assay for diagnosis of human brucellosis. J Clin Microbiol 2003; 41:144.</a></li><li><a class="nounderline abstract_t">Marianelli C, Petrucca A, Pasquali P, et al. Use of MLVA-16 typing to trace the source of a laboratory-acquired Brucella infection. J Hosp Infect 2008; 68:274.</a></li><li><a class="nounderline abstract_t">Al Dahouk S, Flèche PL, Nöckler K, et al. Evaluation of Brucella MLVA typing for human brucellosis. J Microbiol Methods 2007; 69:137.</a></li><li><a class="nounderline abstract_t">Gee JE, De BK, Levett PN, et al. Use of 16S rRNA gene sequencing for rapid confirmatory identification of Brucella isolates. J Clin Microbiol 2004; 42:3649.</a></li><li class="breakAll">Yagupsky, P. Preventing Laboratory-Acquired Brucellosis in the Era of MALDI-TOF Technology and Molecular Tests: A Narrative Review. Zoonotic Dis. 2022; 2:172. https://www.mdpi.com/2813-0227/2/4/16 (Accessed on October 19, 2023).</li><li><a class="nounderline abstract_t">Sharififar R, Heidari K, Mazandarani M, et al. Comparison of the Polymerase Chain Reaction Method with Serological Tests in the Diagnosis of Human Brucellosis. Jundishapur Journal of Microbiology 2023; 16:e128698.</a></li><li><a class="nounderline abstract_t">Pourbagher A, Pourbagher MA, Savas L, et al. Epidemiologic, clinical, and imaging findings in brucellosis patients with osteoarticular involvement. AJR Am J Roentgenol 2006; 187:873.</a></li><li><a class="nounderline abstract_t">Bosilkovski M, Khezzani B, Khezzani I, et al. Increased risk of brucellosis misdiagnosis in regions that lose their endemicity. Trop Biomed 2023; 40:76.</a></li><li><a class="nounderline abstract_t">Turgut M, Cullu E, Sendur OF, Güyrer G. Brucellar spine infection--four case reports. Neurol Med Chir (Tokyo) 2004; 44:562.</a></li><li><a class="nounderline abstract_t">Nas K, Gür A, Kemaloğlu MS, et al. Management of spinal brucellosis and outcome of rehabilitation. Spinal Cord 2001; 39:223.</a></li><li><a class="nounderline abstract_t">Ariza J, Pigrau C, Cañas C, et al. Current understanding and management of chronic hepatosplenic suppurative brucellosis. Clin Infect Dis 2001; 32:1024.</a></li></ol></div><div id="topicVersionRevision">Topic 3140 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15930423" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15930423" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15930423" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16439329" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The new global map of human brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19604656" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Brucellosis: a re-emerging zoonosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19623871" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Natural history of brucellosis in an endemic region in different time periods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17442354" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Brucellosis as a cause of acute febrile illness in Egypt.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12074485" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Bacterial pathogens as biological weapons and agents of bioterrorism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16964579" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Brucella as a biological weapon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30083304" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Comparisons of brucellosis between human and veterinary medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7546364" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Brucellosis: current epidemiology, diagnosis, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7546364" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Brucellosis: current epidemiology, diagnosis, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7546364" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Brucellosis: current epidemiology, diagnosis, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7546364" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Brucellosis: current epidemiology, diagnosis, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23837383" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Bovine brucellosis in wildlife: using adaptive management to improve understanding, technology and suppression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20889883" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Brucellosis in northern Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8336614" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Brucellosis: re-emergence and changing epidemiology in Queensland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8336614" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Brucellosis: re-emergence and changing epidemiology in Queensland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30050849" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Swine brucellosis: current perspectives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17901634" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Review of clinical and laboratory features of human brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17241808" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, laboratory test results, and therapy outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20718086" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Human brucellosis in Macedonia - 10 years of clinical experience in endemic region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20718086" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Human brucellosis in Macedonia - 10 years of clinical experience in endemic region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16249034" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : A rare case of Brucella melitensis infection in an obstetrician during the delivery of a transplacentally infected infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18190307" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The many faces of human-to-human transmission of brucellosis: congenital infection and outbreak of nosocomial disease related to an unrecognized clinical case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8656919" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Brucella melitensis--a sexually transmissible agent?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25236880" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Potential risk of blood transfusion-transmitted brucellosis in an endemic area of China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31782698" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Human brucellosis in pregnancy - an overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31782698" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Human brucellosis in pregnancy - an overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31782698" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Human brucellosis in pregnancy - an overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15879907" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Brucellosis in San Diego: epidemiology and species-related differences in acute clinical presentations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8562733" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : An overview of human brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35653425" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : First Case of Human Brucella canis Infection in the Netherlands.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15603839" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Characteristics of B. melitensis versus B. abortus bacteraemias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12702232" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Human neurobrucellosis with intracerebral granuloma caused by a marine mammal Brucella spp.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17035490" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Characterization of a Brucella sp. strain as a marine-mammal type despite isolation from a patient with spinal osteomyelitis in New Zealand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22739776" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Human exposures to marine Brucella isolated from a harbor porpoise - Maine, 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20696557" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The changing Brucella ecology: novel reservoirs, new threats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21810055" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Implications of laboratory diagnosis on brucellosis therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25242540" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Brucella papionis sp. nov., isolated from baboons (Papio spp.).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26928956" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Brucella vulpis sp. nov., isolated from mandibular lymph nodes of red foxes (Vulpes vulpes).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28518028" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Brucella neotomae Infection in Humans, Costa Rica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34448692" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Genomics of Ochrobactrum pseudogrignonense (newly named Brucella pseudogrignonensis) reveals a new blaOXA subgroup.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15845228" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16364020" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Seroprevalence of brucellosis, tularemia, and yersiniosis in wild boars (Sus scrofa) from north-eastern Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16364020" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Seroprevalence of brucellosis, tularemia, and yersiniosis in wild boars (Sus scrofa) from north-eastern Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Human brucellosis: An overview</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20692128" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Update on laboratory diagnosis of human brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3794323" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Evaluation of ELISA in the diagnosis of acute and chronic brucellosis in human beings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10558306" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Human brucellosis: a classical infectious disease with persistent diagnostic challenges.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12458118" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The diagnosis of brucellosis by use of BACTEC 9240 blood culture system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10523530" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Detection of Brucellae in blood cultures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10523530" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Detection of Brucellae in blood cultures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10523530" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Detection of Brucellae in blood cultures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9721960" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Brucellosis in patients infected with the human immunodeficiency virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24820461" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Human brucellosis in Turkey: different clinical presentations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30476930" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Clinical features of 2041 human brucellosis cases in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8699960" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Complications associated with Brucella melitensis infection: a study of 530 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15635968" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12718832" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Brucellosis in children: clinical observations in 115 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29619483" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Pediatric brucellosis. An update review for the new millennium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15578807" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Osteoarticular involvement in brucellosis: study of 196 cases in the Republic of Macedonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11971204" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Musculoskeletal involvement of brucellosis in different age groups: a study of 195 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23446445" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Osteoarticular involvement in childhood brucellosis: experience with 133 cases in an endemic region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30788222" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Osteoarticular manifestations of human brucellosis: A review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17906836" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Age and duration of disease as factors affecting clinical findings and sacroiliitis in brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6101216" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Articular involvement in human brucellosis: a retrospective analysis of 304 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8329507" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Brucellar sacroiliitis: findings in 63 episodes and current relevance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17344084" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Osteoarticular complications of brucellosis in Hamedan, an endemic area in the west of Iran.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18181740" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Clinical findings, therapeutic approach, and outcome of brucellar vertebral osteomyelitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2330811" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Neurological complications of brucella spondylitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10585793" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Brucellar spondylitis: review of 35 cases and literature survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Complications and treatment of brucellosis: 11-year results</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26159844" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Brucellosis in pregnancy: clinical aspects and obstetric outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11283806" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Brucellosis in pregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30989418" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Brucellosis in pregnancy: results of multicenter ID-IRI study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24480149" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Brucella arteritis: clinical manifestations, treatment, and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13130417" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Brucellosis and the respiratory system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16772417" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years' experience in an endemic area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23907372" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Respiratory system involvement in brucellosis: the results of the Kardelen study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18419433" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Ocular manifestations associated with brucellosis: a 26-year experience in Peru.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2923445" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Characteristic cutaneous lesions in patients with brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23963260" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Brucellosis in low-income and middle-income countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14857606" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : What is chronic brucellosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14857606" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : What is chronic brucellosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18162038" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7620005" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Characteristics of and risk factors for relapse of brucellosis in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15551160" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9028744" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Recognition and optimum treatment of brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9515675" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Multivariate model for predicting relapse in human brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9515675" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Multivariate model for predicting relapse in human brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8362601" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Pancytopenia in children with brucellosis: clinical manifestations and bone marrow findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15591899" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Pancytopenia, a rare hematologic manifestation of brucellosis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : The microbiology laboratory in the diagnosis of infectious arthritis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3883171" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Bacterial arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Reactive arthritis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3823795" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Brucella arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2256735" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Osteoarticular brucellosis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23210984" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Diagnosis of chronic brucellar meningitis and meningoencephalitis: the results of the Istanbul-2 study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2927673" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Neurobrucellosis: clinical characteristics, diagnosis, and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23446629" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Neurobrucellosis: clinical and diagnostic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7756471" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Adenosine deaminase activity in the CSF of patients with aseptic meningitis: utility in the diagnosis of tuberculous meningitis or neurobrucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25869821" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Rational application of adenosine deaminase activity in cerebrospinal fluid for the diagnosis of tuberculous meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22104430" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Evaluation of cerebrospinal fluid adenosine deaminase activity for the differential diagnosis of tuberculous and nontuberculous meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35930502" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Manifestations, complications, and treatment of neurobrucellosis: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36242068" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Neurobrucellosis: report of 54 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29657194" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Association of brucellosis with renal tubular and glomerular damage in children in Turkey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18173070" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : [Brucellosis: retrospective evaluation of the clinical, laboratory and epidemiological features of 151 cases].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14651329" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Laboratory-based diagnosis of brucellosis--a review of the literature. Part II: serological tests for brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18834635" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Influence of brucellosis history on serological diagnosis and evolution of patients with acute brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31722888" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Laboratory Diagnosis of Human Brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31652718" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Acute Febrile Illness Caused by Brucella abortus Infection in Humans in Pakistan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10762113" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Brucella bacteraemia: clinical and laboratory observations in 160 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3941276" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : An evaluation of diagnostic methods for brucellosis--the value of bone marrow culture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12944013" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : The sensitivity and specificity of Brucella agglutination tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12458117" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Comparison of the Brucella Standard Agglutination Test with the ELISA IgG and IgM in patients with Brucella bacteremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1866536" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21526218" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : The Rose Bengal Test in human brucellosis: a neglected test for the diagnosis of a neglected disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19625085" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : The role of Brucellacapt test for follow-up patients with brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19648045" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Follow-up standard agglutination and 2-mercaptoethanol tests in 175 clinically cured cases of human brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11060059" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Evaluation of an immunocapture-agglutination test (Brucellacapt) for serodiagnosis of human brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6356268" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Human brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9570654" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Evaluation of a Brucella enzyme immunoassay test (ELISA) in comparison with bacteriological culture and agglutination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13847578" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : The nature of blocking antibodies in human brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4160424" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Immunoglobulin patterns of antibodies against Brucella in man and animals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2915152" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Changes in IgM and IgG antibody concentrations in brucellosis over time: importance for diagnosis and follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12517839" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Development and evaluation of a PCR-enzyme-linked immunosorbent assay for diagnosis of human brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18289724" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Use of MLVA-16 typing to trace the source of a laboratory-acquired Brucella infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17261338" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Evaluation of Brucella MLVA typing for human brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15297511" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Use of 16S rRNA gene sequencing for rapid confirmatory identification of Brucella isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15297511" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Use of 16S rRNA gene sequencing for rapid confirmatory identification of Brucella isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Comparison of the Polymerase Chain Reaction Method with Serological Tests in the Diagnosis of Human Brucellosis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16985128" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Epidemiologic, clinical, and imaging findings in brucellosis patients with osteoarticular involvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37356006" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Increased risk of brucellosis misdiagnosis in regions that lose their endemicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15633472" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Brucellar spine infection--four case reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11420738" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Management of spinal brucellosis and outcome of rehabilitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11264030" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Current understanding and management of chronic hepatosplenic suppurative brucellosis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
